Barclays Maintains Underweight on Lineage, Raises Price Target to $35

Lineage, Inc.

Lineage, Inc.

LINE

0.00

Barclays analyst Brendan Lynch maintains Lineage (NASDAQ: LINE) with a Underweight and raises the price target from $34 to $35.